Table 1 Clinical characteristics of patients according to CCL17 expression

All patients

286

100

143

143

Age, years

0.811^a

 mean ± SD

55.69 ± 13.46

55.05 ± 13.06

Gender

0.368^b

 Female

87

30.4

47

40

 Male

199

69.6

96

103

Tumor size, cm

0.173^a

 mean ± SD

5.04 ± 2.76

4.58 ± 2.56

Pathological T stage

0.301^c

 pT1

181

63.3

85

96

 pT2

26

9.1

16

10

 pT3

75

26.2

40

35

 pT4

4

1.4

2

2

Pathological N stage

1.000^b

 pNx

240

83.9

120

120

 pN0

44

15.4

22

22

 pN1

2

0.7

1

1

Distant metastasis

0.063^b

 No

271

94.8

132

139

 Yes

15

5.2

11

4

TNM stage

0.122^c

 I

175

61.2

79

96

 II

23

8.0

13

10

 III

69

24.1

35

34

 IV

19

6.6

14

5

Fuhrman grade

0.456^c

 1

32

11.2

17

15

 2

209

73.1

99

110

 3

41

14.3

25

16

 4

4

1.4

2

2

Necrosis

0.866^b

 Absent

245

85.7

123

122

 Present

41

14.3

20

21

ECOG PS

0.003^b

 0

208

72.7

93

115

  ≥ 1

78

27.3

50

28

UISS category

0.277^c

 Low risk

119

41.6

54

65

 Mediate risk

127

44.4

63

64

 High risk

40

14.0

24

16

SSIGN category

0.143^c

 0–3

218

76.2

105

113

 5–7

62

21.8

33

29

 8+

6

2.1

5

1